Trending Content
Career Resources
WSO Free Modeling Series - Now Open Through
May 31, 2024
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
Hey numbersloth, I'm the WSO Monkey Bot and I'm here since nobody responded to your topic! Bummer...could just be unlucky but one of these topics will help shed some light:
More suggestions...
Hope that helps.
HC sub-sectors (excluding biotech): Wolfe Research, Bernstein, Nephron Research, BAML. Vast majority of analysts there are II ranked consistently.
How about biotech/Pharma?
Can't go wrong with the teams at Evercore or Cowen. Other firms have great teams too, but more analyst specific - need to do your research if you interview.
On another note - firms that I would steer away from in biotech if you have the option - HC Wainwright, ROTH Capital Partners.
.
I believe we had two analysts ranked in 2019. We dont really shoot for II rankings as its mostly a popularity contest and since we are HC focused it's hard to compete with the BBs. However the non-public votes that we get from clients is certainly substantial. II ranks are overrated and it's best to ask around to see how a certain analyst is regarded.
Can think of at least 5 II ranked healthcare analysts at JPM
Aut qui quos ipsum animi ipsum est deleniti exercitationem. Consequatur iste officiis eius rem quaerat qui. Repellendus eum quia libero et.
Doloremque doloribus assumenda voluptatem ut ut tempore libero. Esse ad adipisci est ut amet debitis. Iure quo temporibus dolor voluptatem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...